Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours

NCT06430502 is registered in ClinicalTrials.gov with Wuxi People's Hospital as lead sponsor.

NCT NCT06430502
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06430502 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Efficacy of Tumour Treatment Vaccine (TTV) Combined With PD-1 in the Treatment of Relapsed Refractory Advanced Solid Tumours
Lead sponsor
Wuxi People's Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
May 7, 2024
Completion date
December 1, 2027
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pd-l1 gene mutation